Measurement of lupus anticoagulants: An update on quality in laboratory testing

Seminars in Thrombosis and Hemostasis

Volumn 39, Issue 3, 2013, Pages 267-271

  Adams, Murray ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

antiphospholipid antibodies; guidelines; lupus anticoagulant; quality assurance; standardization

Indexed keywords

ANTIVITAMIN K; DABIGATRAN; HEPARIN; LUPUS ANTICOAGULANT; RIVAROXABAN;

ARTICLE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; LABORATORY TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION; CLINICAL LABORATORY TECHNIQUES; FEMALE; GUIDELINES AS TOPIC; HUMANS; LUPUS COAGULATION INHIBITOR; PREGNANCY;

EID: 84875465645     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0033-1334864     Document Type: Article

References (49)

1. Feinstein D. I., Rapaport S. I. Acquired inhibitors of blood coagulation. Prog Hemost Thromb: 1972; 1 75 95
2. Pasoto S. G., Chakkour H. P., Natalino R. R., et al. Lupus anticoagulant: a marker for stroke and venous thrombosis in primary Sjögren's syndrome. Clin Rheumatol: 2012; 31 9 1331 1338
3. Rai R. S., Regan L., Clifford K., et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod: 1995; 10 8 2001 2005
4. Parazzini F., Acaia B., Faden D., Lovotti M., Marelli G., Cortelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol: 1991; 77 6 854 858
5. Boey M. L., Colaco C. B., Gharavi A. E., Elkon K. B., Loizou S., Hughes G. R. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed): 1983; 287 6398 1021 1023 (Pubitemid 13009248)
6. Galli M., Luciani D., Bertolini G., Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood: 2003; 101 5 1827 1832 (Pubitemid 36237580)
7. Kampe C. E. Clinical syndromes associated with lupus anticoagulants. Semin Thromb Hemost: 1994; 20 1 16 26 (Pubitemid 24168805)
8. Favaloro E. J. Trials and tribulations in lupus anticoagulant testing. Clin Chem Lab Med: 2013; 51 2 253 256
9. Favaloro E. J., Wong R. C. The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours? Autoimmunity Highlights: 2010; 1 5 14
10. Favaloro E. J., Wong R. C. Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med: 2011; 49 3 447 461
11. Miyakis S., Lockshin M. D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: 2006; 4 2 295 306
12. Palatinus A., Adams M. Thrombosis in systemic lupus erythematosus. Semin Thromb Hemost: 2009; 35 7 621 629
13. Reber G., Meijer P. In ECAT veritas? Lupus: 2012; 21 7 722 724
14. Green D., Hougie C., Kazmier F. J., et al. Report of the Working Party on Acquired Inhibitors of Coagulation: studies of the "lupuso" anticoagulant. Thromb Haemost: 1983; 49 2 144 146 (Pubitemid 13124992)
15. Brandt J. T., Triplett D. A., Alving B., Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost: 1995; 74 4 1185 1190
16. Exner T., Triplett D. A., Taberner D., Machin S. J. SSC Subcommittee for the Standardization of Lupus Anticoagulants Guidelines for testing and revised criteria for lupus anticoagulants. Thromb Haemost: 1991; 65 3 320 322
17. Pengo V., Tripodi A., Reber G., et al. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost: 2009; 7 10 1737 1740
18. Favaloro E. J., Bonar R., Zebeljan D., Kershaw G., Marsden K. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost: 2010; 8 12 2828 2831
19. Pengo V., Ruffatti A., Legnani C., et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost: 2010; 8 2 237 242
20. Kershaw G., Suresh S., Orellana D., Nguy Y. M. Laboratory identification of lupus anticoagulants. Semin Thromb Hemost: 2012; 38 4 375 384
21. Lippi G., Brentegani C., Cocco C., Lo Cascio C., Guidi G. Paradoxical behaviour of lyophilised commercial control materials for CK and CK-MB assays after reconstitution at either 4 degrees C or 24 degrees C. Clin Chim Acta: 1997; 261 2 167 173 (Pubitemid 27214574)
22. Favaloro E. J., Bonar R., Marsden K. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II-Lupus anticoagulant. Semin Thromb Hemost: 2012; 38 4 404 411
23. Bonar R., Favaloro E. J., Adcock D. M. Quality in laboratory diagnostics: from theory to practice. Biochem Med (Zagreb): 2010; 20 2 184 199
24. Pradella P., Azzarini G., Santarossa L., et al. Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays. Clin Chem Lab Med: 2013; 51 2 379 385
25. Tripodi A. To mix or not to mix in lupus anticoagulant testing? That is the question. Semin Thromb Hemost: 2012; 38 4 385 389
26. Favaloro E. J., Wheatland L., Jovanovich S., Roberts-Thomson P., Wong R. C. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I-Anticardiolipin and anti-β2- glycoprotein I antibodies. Semin Thromb Hemost: 2012; 38 4 390 403
27. Bonar R., Favaloro E., Zebeljan D., et al. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP. Pathology: 2012; 44 3 240 247
28. Tripodi A., Pengo V. More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost: 2011; 9 10 2126 2127
29. Devreese K. M. No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants? J Thromb Haemost: 2010; 8 5 1120 1122
30. Martinuzzo M. E., Cerrato G. S., Varela M. L., Adamczuk Y. P., Forastiero R. R. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests. Int J Lab Hematol: 2012; 34 2 208 213
31. Aboud M., Roddie C., Ward C., Coyle L. To mix with pooled normal plasma or not to mix: a comparative study of 2 approaches for assessing lupus anticoagulant inhibitory activity in the dilute Russell viper venom method. Clin Chem: 2007; 53 1 143 145 (Pubitemid 46047778)
32. Moore G. W., Savidge G. F. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thromb Res: 2006; 118 4 523 528 (Pubitemid 44292799)
33. Thom J., Ivey L., Eikelboom J. Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant. J Thromb Haemost: 2003; 1 12 2689 2691
34. Moffat K. A., Ledford-Kraemer M. R., Plumhoff E. A., et al. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices. Thromb Haemost: 2009; 101 1 178 184
35. Dembitzer F. R., Ledford Kraemer M. R., Meijer P., Peerschke E. I. Lupus anticoagulant testing: performance and practices by North American clinical laboratories. Am J Clin Pathol: 2010; 134 5 764 773
36. Jennings I., Greaves M., Mackie I. J., Kitchen S., Woods T. A., Preston F. E. UK National External Quality Assessment Scheme for Blood Coagulation Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol: 2002; 119 2 364 369 (Pubitemid 35365483)
37. Greaves M., Cohen H., MacHin S. J., Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol: 2000; 109 4 704 715 (Pubitemid 30609746)
38. Tripodi A., Chantarangkul V., Clerici M., Mannucci P. M. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Thromb Haemost: 2002; 88 4 583 586 (Pubitemid 35173998)
39. Alkayed K., Kottke-Marchant K. Indeterminate lupus anticoagulant results: prevalence and clinical significance. Korean J Hepatol: 2011; 46 4 239 243
40. Favaloro E. J., Lippi G. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against? Clin Chem Lab Med: 2011; 49 5 755 757
41. Favaloro E. J., Lippi G., Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology: 2011; 43 7 682 692
42. Harenberg J., Erdle S., Marx S., Krämer R. Determination of rivaroxaban in human plasma samples. Semin Thromb Hemost: 2012; 38 2 178 184
43. Harenberg J., Giese C., Marx S., Krämer R. Determination of dabigatran in human plasma samples. Semin Thromb Hemost: 2012; 38 1 16 22
44. Tripodi A. Problems and solutions for testing hemostasis assays while patients are on anticoagulants. Semin Thromb Hemost: 2012; 38 6 586 592
45. Favaloro E. J., Lippi G. The new oral anticoagulants and the future of haemostasis laboratory testing. Biochem Med (Zagreb): 2012; 22 3 329 341
46. de Groot P. G., Urbanus R. T. The future of antiphospholipid antibody testing. Semin Thromb Hemost: 2012; 38 4 412 420
47. Willis R., Harris E. N., Pierangeli S. S. Current international initiatives in antiphospholipid antibody testing. Semin Thromb Hemost: 2012; 38 4 360 374
48. Willis R., Harris E. N., Pierangeli S. S. Pathogenesis of the antiphospholipid syndrome. Semin Thromb Hemost: 2012; 38 4 305 321
49. Teruya J., West A. G., Suell M. N. Lupus anticoagulant assays: questions answered and to be answered. Arch Pathol Lab Med: 2007; 131 6 885 889 (Pubitemid 46906379)